Ms. Bain serves as Chief Operating Officer and Chief Financial Officer for Mariana Oncology. She brings extensive experience in strategic planning, finance, transactions, operations, investor relations, corporate communications and program management.
Previously, Ms. Bain served as Chief Financial Officer of Codiak BioSciences, where she led a successful initial public offering (IPO) and follow-on financings. Prior to that she was Chief Financial Officer of Avalanche Biotechnologies, where she also led an IPO and follow-on financing. Additionally, she served as Vice President of Finance, Business Operations, and Treasurer at bluebird bio, where she led a successful IPO.
Ms. Bain also held senior roles at Genzyme Corporation where she was Vice President of Finance, Global Manufacturing and Operations, and Vice President of Finance, Genzyme Genetics. Earlier in her career, she held senior roles at Fidelity Investments, AstraZeneca, and Deloitte & Touche.
Ms. Bain currently serves on the Board of Directors of Autolus Therapeutics, a publicly-traded company, and Hemab Therapeutics, a private company. She is a Certified Public Accountant and earned a Bachelor of Science in Accounting and Business Administration, as well as an Honors degree in Accounting and Business Administration, from the University of the Free State, Bloemfontein, South Africa.
You are now leaving arvinas.com. Arvinas does not endorse or recommend the content in any third-party sites. Arvinas is not responsible and disclaims liability for the content, or for any viruses or similar harmful programs, that may be present on third-party pages or sites. Visits to a third-party website are at your own risk and subject to the terms and conditions and privacy policy of such site.
